HomeAI · summaries
Storia in 6 fonti
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analy
Pfizer (PFE) will release Q2 earnings on Aug. 4, expected to report lower EPS of 68 cents and revenue at $14.39B. Stock rose 0.1% on Monday.
- ·
swissinfo.ch
Pfizer Raises Sales Guidance on High Demand for Older Drugs
(Bloomberg) -- Pfizer Inc. raised the midpoint of its 2026 sales forecast after reporting strong second-quarter demand for older medicines.
